119th Congress · introduced in the House · Jan 3, 2025
Rural 340B Access Act of 2025
Official title from Congress.gov
Latest action (Jan 3, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in House (Jan 3, 2025)
Rural 340B Access Act of 2025
This bill makes rural emergency hospitals (REHs) eligible to purchase drugs from manufacturers at discounted prices by participating in the Health Resources and Services Administration’s (HRSA’s) 340B drug pricing program. HRSA’s 340B program requires drug manufacturers that participate in the Medicaid program to sell certain outpatient drugs at discounted prices to entities listed as eligible under current law. Additionally, in 2020, Congress established REHs as a new Medicare provider designation for hospitals in rural areas providing emergency department services, observation care, and other outpatient medical and health services for which the annual per patient average length of stay does not exceed 24 hours. The bill adds qualifying REHs to the list of entities that are eligible to participate in the 340B program.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Health care costs and insurance · Health care coverage and access · Hospital care · Prescription drugs · Rural conditions and development
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
7 citations.
340B HEALTH · lobbying firm or registrant: 340B HEALTH
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 9, 2026 · issue area: Pharmacy
$337,176
Spent on own lobbying
…Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug d…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
340B HEALTH · lobbying firm or registrant: 340B HEALTH
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Pharmacy
$285,256
Spent on own lobbying
…Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug d…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
340B HEALTH · lobbying firm or registrant: 340B HEALTH
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Pharmacy
$364,648
Spent on own lobbying
…Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug d…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
340B HEALTH · lobbying firm or registrant: 340B HEALTH
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · amended · posted Sep 15, 2025 · issue area: Pharmacy
$371,483
Spent on own lobbying
…Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug d…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 22, 2025 · issue area: Pharmacy
$4,050,000
Spent on own lobbying
…icaid eligibility and state financing, Marketplace coverage and enrollment, Health Savings Account expansion, Pharmacy Benefit Manager financing and regulation H.R. 44 - 340B Access Act - Rep. Bergman, Jack - 340B participation expansion H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Gene…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 22, 2025 · issue area: Pharmacy
$4,830,000
Spent on own lobbying
H.R. 44 - 340B Access Act - Rep. Bergman, Jack - 340B participation expansion H.R. 843 - Prompt Approval of Safe Generic Drugs Act - Rep. Barragan, Nanette Diaz - Gene…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
340B HEALTH · lobbying firm or registrant: 340B HEALTH
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · amended · posted Apr 21, 2025 · issue area: Pharmacy
$387,126
Spent on own lobbying
…Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug d…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing